1
|
Yoo C, Xing D, Gonzalez DE, Jenkins V, Nottingham K, Dickerson B, Leonard M, Ko J, Lewis MH, Faries M, Kephart W, Purpura M, Jäger R, Wells SD, Liao K, Sowinski R, Rasmussen CJ, Kreider RB. Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run. J Int Soc Sports Nutr 2024; 21:2352779. [PMID: 38725238 PMCID: PMC11089923 DOI: 10.1080/15502783.2024.2352779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2024] [Accepted: 05/01/2024] [Indexed: 05/15/2024] Open
Abstract
RATIONALE Intense exercise promotes fatigue and can impair cognitive function, particularly toward the end of competition when decision-making is often critical for success. For this reason, athletes often ingest caffeinated energy drinks prior to or during exercise to help them maintain focus, reaction time, and cognitive function during competition. However, caffeine habituation and genetic sensitivity to caffeine (CA) limit efficacy. Paraxanthine (PX) is a metabolite of caffeine reported to possess nootropic properties. This study examined whether ingestion of PX with and without CA affects pre- or post-exercise cognitive function. METHODS 12 trained runners were randomly assigned to consume in a double-blind, randomized, and crossover manner 400 mg of a placebo (PL); 200 mg of PL + 200 mg of CA; 200 mg of PL + 200 mg of PX (ENFINITY®, Ingenious Ingredients); or 200 mg PX + 200 mg of CA (PX+CA) with a 7-14-day washout between treatments. Participants donated fasting blood samples and completed pre-supplementation (PRE) side effects questionnaires, the Berg-Wisconsin Card Sorting Test (BCST), and the Psychomotor Vigilance Task Test (PVTT). Participants then ingested the assigned treatment and rested for 60 minutes, repeated tests (PRE-EX), performed a 10-km run on a treadmill at a competition pace, and then repeated tests (POST-EX). Data were analyzed using General Linear Model (GLM) univariate analyses with repeated measures and percent changes from baseline with 95% confidence intervals. RESULTS BCST correct responses in the PX treatment increased from PRE-EX to POST-EX (6.8% [1.5, 12.1], p = 0.012). The error rate in the PL (23.5 [-2.8, 49.8] %, p = 0.078) and CA treatment (31.5 [5.2, 57.8] %, p = 0.02) increased from PRE-EX values with POST-EX errors tending to be lower with PX treatment compared to CA (-35.7 [-72.9, 1.4] %, p = 0.059). POST-EX perseverative errors with PAR rules were significantly lower with PX treatment than with CA (-26.9 [-50.5, -3.4] %, p = 0.026). Vigilance analysis revealed a significant interaction effect in Trial #2 mean reaction time values (p = 0.049, η p 2 = 0.134, moderate to large effect) with POST-EX reaction times tending to be faster with PX and CA treatment. POST-EX mean reaction time of all trials with PX treatment was significantly faster than PL (-23.2 [-43.4, -2.4] %, p = 0.029) and PX+CA (-29.6 [-50.3, -8.80] %, p = 0.006) treatments. There was no evidence that PX ingestion adversely affected ratings of side effects associated with stimulant intake or clinical blood markers. CONCLUSIONS Results provide some evidence that pre-exercise PX ingestion improves prefrontal cortex function, attenuates attentional decline, mitigates cognitive fatigue, and improves reaction time and vigilance. Adding CA to PX did not provide additional benefits. Therefore, PX ingestion may serve as a nootropic alternative to CA.
Collapse
Affiliation(s)
- Choongsung Yoo
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Dante Xing
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Drew E. Gonzalez
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Victoria Jenkins
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Kay Nottingham
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Broderick Dickerson
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Megan Leonard
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Joungbo Ko
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Megan H. Lewis
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Mark Faries
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
- Texas A&M University, Texas A&M AgriLife Extension, College Station, TX, USA
| | - Wesley Kephart
- University of Wisconsin – Whitewater, Department of Kinesiology, Whitewater, WI, USA
| | - Martin Purpura
- Increnovo LLC, Milwaukee, WI, USA
- Ingenious Ingredients LP, Lewisville, TX, USA
| | - Ralf Jäger
- Increnovo LLC, Milwaukee, WI, USA
- Ingenious Ingredients LP, Lewisville, TX, USA
| | | | - Kylin Liao
- Ingenious Ingredients LP, Lewisville, TX, USA
| | - Ryan Sowinski
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Christopher J. Rasmussen
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| | - Richard B. Kreider
- Texas A&M University, Exercise & Sport Nutrition Laboratory, Human Clinical Research Facility, Department of Health & Kinesiology, College Station, TX, USA
| |
Collapse
|
2
|
Trujillo-Colmena D, Fernández-Sánchez J, Rodríguez-Castaño A, Casado A, Del Coso J. Effects of Caffeinated Coffee on Cross-Country Cycling Performance in Recreational Cyclists. Nutrients 2024; 16:668. [PMID: 38474796 PMCID: PMC10933887 DOI: 10.3390/nu16050668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Revised: 02/26/2024] [Accepted: 02/27/2024] [Indexed: 03/14/2024] Open
Abstract
The ergogenic effects of acute caffeine intake on endurance cycling performance lasting ~1 h have been well documented in controlled laboratory studies. However, the potential benefits of caffeine supplementation in cycling disciplines such as cross-country/mountain biking have been rarely studied. In cross-country cycling, performance is dependent on endurance capacity, which may be enhanced by caffeine, but also on the technical ability of the cyclist to overcome the obstacles of the course. So, it is possible that the potential benefits of caffeine are not translated to cross-country cycling. The main objective of this study was to investigate the effects of acute caffeine intake, in the form of coffee, on endurance performance during a cross-country cycling time trial. Eleven recreational cross-country cyclists (mean ± SD: age: 22 ± 3 years; nine males and two females) participated in a single-blinded, randomised, counterbalanced and crossover experiment. After familiarisation with the cross-country course, participants completed two identical experimental trials after the ingestion of: (a) 3.00 mg/kg of caffeine in the form of soluble coffee or (b) 0.04 mg/kg of caffeine in the form of decaffeinated soluble coffee as a placebo. Drinks were ingested 60 min before performing a 13.90 km cross-country time trial over a course with eight sectors of varying technical difficulty. The time to complete the trial and the mean and the maximum speed were measured through Global Positioning System (GPS) technology. Heart rate was obtained through a heart rate monitor. At the end of the time trial, participants indicated their perceived level of fatigue using the traditional Borg scale. In comparison to the placebo, caffeine intake in the form of coffee significantly reduced the time to complete the trial by 4.93 ± 4.39% (43.20 ± 7.35 vs. 41.17 ± 6.18 min; p = 0.011; effect size [ES] = 0.300). Caffeine intake reduced the time to complete four out of eight sectors with different categories of technical difficulty (p ≤ 0.010; ES = 0.386 to 0.701). Mean heart rate was higher with caffeine (169 ± 6 vs. 162 ± 13 bpm; p = 0.046; ES = 0.788) but the rating of perceived exertion at the end of the trial was similar with caffeinated coffee than with the placebo (16 ± 1 vs. 16 ± 2 a.u.; p = 0.676; ES = 0.061). In conclusion, the intake of 3 mg/kg of caffeine delivered via soluble coffee reduced the time to complete a cross-country cycling trial in recreational cyclists. These results suggest that caffeine ingested as coffee may be an ergogenic substance for cross-country cycling.
Collapse
Affiliation(s)
- Daniel Trujillo-Colmena
- Sport Sciences Research Centre, Rey Juan Carlos University, 28943 Madrid, Spain; (D.T.-C.); (J.F.-S.); (A.R.-C.); (A.C.)
- Program of Epidemiology and Public Health (Interuniversity), Ph.D. International School, Rey Juan Carlos University, 28943 Madrid, Spain
| | - Javier Fernández-Sánchez
- Sport Sciences Research Centre, Rey Juan Carlos University, 28943 Madrid, Spain; (D.T.-C.); (J.F.-S.); (A.R.-C.); (A.C.)
| | - Adrián Rodríguez-Castaño
- Sport Sciences Research Centre, Rey Juan Carlos University, 28943 Madrid, Spain; (D.T.-C.); (J.F.-S.); (A.R.-C.); (A.C.)
| | - Arturo Casado
- Sport Sciences Research Centre, Rey Juan Carlos University, 28943 Madrid, Spain; (D.T.-C.); (J.F.-S.); (A.R.-C.); (A.C.)
| | - Juan Del Coso
- Sport Sciences Research Centre, Rey Juan Carlos University, 28943 Madrid, Spain; (D.T.-C.); (J.F.-S.); (A.R.-C.); (A.C.)
| |
Collapse
|
3
|
Isenmann E, Tolle P, Geisler S, Flenker U, Diel P. Differences in Consumption Behaviour of Dietary Supplements in Competitive Athletes Depends on Sports Discipline. Nutrients 2024; 16:374. [PMID: 38337659 PMCID: PMC10857381 DOI: 10.3390/nu16030374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2023] [Revised: 01/23/2024] [Accepted: 01/24/2024] [Indexed: 02/12/2024] Open
Abstract
BACKGROUND The consumption of dietary supplements (DS) is widespread among the general population and competitive athletes. However, only a few competitive athletes seek information from experts about the effects and use of DS. Furthermore, it is currently unknown whether certain sports have a higher affinity for DS than others. METHODS This study aimed to identify differences between different sports categories and subgroups that may have a very high affinity for DS. For this purpose, competitive athletes were surveyed. The survey included the type of sport, the training frequency, the number of competitions, the consumption behaviour of five DS categories (general health, regeneration promotion, performance enhancement, booster, and weight loss) as well as personal data such as biological sex and age. Subsequently, correlations, configural frequencies (CFA), and multiple correspondence analyses (MCA) were used to identify subgroups with a high affinity of consumption behaviour. RESULTS A total of 409 questionnaires could be evaluated. It was found that all DS categories except weight loss were related. In addition, it was observed that in sports from the power category and from the endurance category, there was even higher consumption behaviour than in other sports categories. Male power athletes in particular have a higher affinity for consuming DS than other subgroups. CONCLUSIONS This study shows that there is a clear different consumption behaviour depending on the type of sport. Male power athletes in particular are the subgroup with the greatest consumption behaviour and therefore require special education on the effects and use of DS. This subgroup in particular should receive increased attention in counselling on DS to minimise the possible risks of DS use.
Collapse
Affiliation(s)
- Eduard Isenmann
- Department of Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sports University Cologne, 50933 Cologne, Germany; (P.T.); (U.F.); (P.D.)
- Department of Fitness and Health, IST-University of Applied Sciences, 40233 Dusseldorf, Germany;
| | - Pia Tolle
- Department of Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sports University Cologne, 50933 Cologne, Germany; (P.T.); (U.F.); (P.D.)
| | - Stephan Geisler
- Department of Fitness and Health, IST-University of Applied Sciences, 40233 Dusseldorf, Germany;
| | - Ulrich Flenker
- Department of Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sports University Cologne, 50933 Cologne, Germany; (P.T.); (U.F.); (P.D.)
| | - Patrick Diel
- Department of Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sports University Cologne, 50933 Cologne, Germany; (P.T.); (U.F.); (P.D.)
| |
Collapse
|
4
|
Tsai KZ, Huang WC, Sui X, Lavie CJ, Lin GM. Moderate or greater daily coffee consumption is associated with lower incidence of metabolic syndrome in Taiwanese militaries: results from the CHIEF cohort study. Front Nutr 2023; 10:1321916. [PMID: 38156279 PMCID: PMC10752930 DOI: 10.3389/fnut.2023.1321916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2023] [Accepted: 12/05/2023] [Indexed: 12/30/2023] Open
Abstract
Background Daily moderate coffee intake was found with a lower risk of specific metabolic abnormalities, e.g., hypertension and hyperglycemia, while the association of coffee intake and incident metabolic syndrome (MetS) has not been clarified in prior studies, particularly in young adults. Methods A total of 2,890 military personnel, aged 18-39 years, free of MetS were followed for incident MetS from baseline (2014) until the end of 2020 in Taiwan. Daily coffee amount consumed was grouped to those ≥3 cups or 600 mL (moderate or more amount) and those without. Incidence of MetS was identified in annual health examinations. MetS was diagnosed on the basis of the guideline of the International Diabetes Federation. Multivariable Cox regression model with adjustments for sex, age, body mass index, physical activity and substance use status at baseline was performed to determine the association. Results At baseline, there were 145 subjects with daily coffee intake ≥3 cups or 600 mL (5.0%) in the overall cohort. During a mean follow-up of 6.0 years, 673 incident MetS (23.3%) were found. As compared to those consuming less coffee or none, those consuming daily coffee ≥3 cups had a lower risk of MetS [hazard ratio (HR): 0.69 (95% confidence interval: 0.48, 0.99)]. Conclusion This study suggests that adhering to the guideline recommended moderate or greater daily coffee consumption for promoting health, may confer advantages in preventing the development of MetS among young adults.
Collapse
Affiliation(s)
- Kun-Zhe Tsai
- Department of Stomatology of Periodontology, Mackay Memorial Hospital, Taipei, Taiwan
- Department of Medicine, Hualien Armed Forces General Hospital, Hualien City, Taiwan
- Department of Periodontology, School of Dentistry, National Defense Medical Center and Tri-Service General Hospital, Taipei, Taiwan
| | - Wei-Chun Huang
- Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
- College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
| | - Xuemei Sui
- Arnold School of Public Health, University of South Carolina, Columbia, SC, United States
| | - Carl J. Lavie
- Ochsner Clinical School, John Ochsner Heart and Vascular Institute, The University of Queensland School of Medicine, New Orleans, LA, United States
| | - Gen-Min Lin
- Department of Medicine, Hualien Armed Forces General Hospital, Hualien City, Taiwan
- Department of Medicine, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
| |
Collapse
|